Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (<scp>MACVIA</scp>‐<scp>ARIA</scp>) ‐ <scp>EIP</scp> on <scp>AHA</scp> Twinning Reference Site (<scp>GARD</scp> research demonstration project)

  • J. Bousquet
    MACVIA‐France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
  • I. Agache
    Faculty of Medicine Transylvania University Brasov Romania
  • M. R. Aliberti
    Municipality of Salerno Salerno Italy
  • R. Angles
    Innovación y nuevas tecnologías, Salud Sector sanitario de Barbastro Barbastro Spain
  • I. Annesi‐Maesano
    EPAR U707 INSERM Paris France
  • J. M. Anto
    ISGLoBAL Centre for Research in Environmental Epidemiology (CREAL) Barcelona Spain
  • S. Arnavielhe
    Kyomed Montpellier France
  • E. Asayag
    Argentine Society of Allergy and Immunopathology Buenos Aires Argentina
  • E. Bacci
    Regione Liguria Genoa Italy
  • A. Bedbrook
    MACVIA‐France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
  • C. Bachert
    Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
  • I. Baroni
    Telbios SRL Milan Italy
  • B. A. Barreto
    Alergologo Belem Brazil
  • M. Bedolla‐Barajas
    Hospital Civil de Guadalajara Dr. Juan I. Menchaca Guadalarara Mexico
  • K. C. Bergmann
    Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité‐Universitätsmedizin Berlin Berlin Germany
  • L. Bertorello
    Regione Liguria Genoa Italy
  • M. Bewick
    iQ4U Consultants Ltd London UK
  • T. Bieber
    Department of Dermatology and Allergy Rheinische Friedrich‐Wilhelms‐University Bonn Germany
  • S. Birov
    Empirica Communication and Technology Research Bonn Germany
  • C. Bindslev‐Jensen
    Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark
  • A. Blua
    Argentine Association of Respiratory Medicine Buenos Aires Argentina
  • M. Bochenska Marciniak
    Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
  • I. Bogus‐Buczynska
    Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
  • S. Bosnic‐Anticevich
    Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
  • I. Bosse
    Allergist La Rochelle France
  • R. Bourret
    Centre Hospitalier Valenciennes Valenciennes France
  • C. Bucca
    Chief of the University Pneumology Unit‐ AOU Molinette Hospital City of Health and Science of Torino Torino Italy
  • R. Buonaiuto
    Pharmacist of COFASER ‐ Consorzio Farmacie Servizi‐Salerno Salerno Italy
  • M. T. Burguete Cabanas
    Centro Médico Zambrano Hellion Monterrey Mexico
  • D. Caillaud
    Service de pneumologie CHU et université d'Auvergne Clermont‐Ferrand France
  • D. P. Caimmi
    Department of Respiratory Diseases Montpellier University Hospital Montpellier France
  • D. Caiazza
    Pharmacist of COFASER ‐ Consorzio Farmacie Servizi‐Salerno Salerno Italy
  • P. Camargos
    Department of Pediatrics Medical School Federal University of Minas Gerais Belo Horizonte Brazil
  • G. Canfora
    Mayor of Sarno and President of Salerno Province Anesthesiology Service, Sarno “Martiri del Villa Malta” Hospital Sarno Italy
  • V. Cardona
    S. Allergologia, S. Medicina Interna Hospital Vall d'Hebron Barcelona Spain
  • A. M. Carriazo
    Regional Ministry of Health of Andalusia Seville Spain
  • C. Cartier
    ASA ‐ Advanced Solutions Accelerator Clapiers France
  • G. Castellano
    Celentano Pharmacy Massa Lubrense Italy
  • N. H. Chavannes
    Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
  • L. Cecci
    S.O.S Allergology and Clinical Immunology USL Toscana Centro Prato Italy
  • M. M. Ciaravolo
    Specialist Social Worker Sorrento Italy
  • C. Cingi
    ENT Department Medical Faculty Eskisehir Osmangazi University Eskisehir Turkey
  • A. Ciceran
    Argentine Federation of Otorhinolaryngology Societies Buenos Aires Argentina
  • L. Colas
    Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax University of Nantes Nantes France
  • E. Colgan
    Department of Health, Social Services and Public Safety Belfast UK
  • J. Coll
    Innovación y nuevas tecnologías Salud Sector sanitario de Barbastro Barbastro Spain
  • D. Conforti
    Fondazione Bruno Kessler (FBK) Trento Italy
  • J. Correia de Sousa
    Life and Health Sciences Research Institute (ICVS) School of Health Sciences University of Minho Braga Portugal
  • R. M. Cortés‐Grimaldo
    Alergologa Guadalarara Mexico
  • F. Corti
    FIMMG (Federazione Italiana Medici di Medicina Generale) Milan Italy
  • E. Costa
    UCIBIO, REQYULTE Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork) Porto Portugal
  • A. L. Courbis
    Ecole des Mines Alès France
  • E. Cousein
    Vice Président de la CME ‐ Centre Hospitalier Valenciennes France
  • A. A. Cruz
    ProAR – Nucleo de Excelencia em Asma Federal University of Bahia Bahia Brazil
  • A. Custovic
    Department of Pediatric Imperial College London London UK
  • B. Cvetkovski
    Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
  • C. Dario
    Azienda Provinciale per i Servizi Sanitari di Trento (APSS‐Trento) Trento Italy
  • J. da Silva
    Allergy Service University Hospital of Federal University of Santa Catarina (HU‐UFSC) Florianópolis Brazil
  • Y. Dauvilliers
    Sleep Unit Department of Neurology Hôpital Gui‐de‐Chauliac Montpellier, Inserm U1061 Montpellier France
  • F. De Blay
    Allergy Division Chest Disease Department University Hospital of Strasbourg Strasbourg France
  • T. Dedeu
    AQuAS, Barcelona, Spain & EUREGHA, European Regional and Local Health Association Brussels Belgium
  • G. De Feo
    Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy
  • B. De Martino
    Social Workers Coordinator Sorrento Italy
  • P. Demoly
    Department of Respiratory Diseases Montpellier University Hospital Montpellier France
  • G. De Vries
    Peercode DV Gerdermalsen The Netherlands
  • S. Di Capua Ercolano
    Farmacie Dei Golfi Group Massa Lubrense Italy
  • N. Di Carluccio
    Pharmacist of COFASER ‐ Consorzio Farmacie Servizi‐Salerno Salerno Italy
  • M. Doulapsi
    Department of Otolaryngology University of Crete School of Medicine Heraklion Greece
  • G. Dray
    Ecole des Mines Alès France
  • R. Dubakiene
    Medical Faculty Vilnius University Vilnius Lithuania
  • E. Eller
    Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark
  • R. Emuzyte
    Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania
  • J. G. Espinoza‐Contreras
    University of Aguascalientes Chihuaha Mexico
  • A. Estrada‐Cardona
    Alergologo Playa del Carmen Mexico
  • J. Farrell
    Department of Health, Social Services and Public Safety Belfast UK
  • A. Farsi
    S.O.S Allergology and Clinical Immunology USL Toscana Centro Prato Italy
  • J. Ferrero
    Andalusian Agency for Healthcare Quality Seville Spain
  • W. J. Fokkens
    Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands
  • J. Fonseca
    Center for Health Technology and Services Research‐ CINTESIS Faculdade de Medicina Universidade do Porto Porto Portugal
  • J. F. Fontaine
    Allergist Reims France
  • S. Forti
    Fondazione Bruno Kessler (FBK) Trento Italy
  • J. L. Gálvez‐Romero
    Regional Hospital of ISSSTE Puebla Mexico
  • C. I. García‐Cobas
    Alergologo Guadalarara Mexico
  • M. H. Garcia Cruz
    Allergy Clinic National Institute of Respiratory Diseases Mexico City Mexico
  • B. Gemicioğlu
    Department of Pulmonary Diseases Cerrahpasa Faculty of Medicine Istanbul University Istanbul Turkey
  • R. Gerth van Wijk
    Department of Internal Medicine Section of Allergology Erasmus MC Rotterdam The Netherlands
  • M. Guidacci
    Member of the Brazilian Society of Pediatrics and Society of Immunization Representative of GINA (Global Initiative Against Asthma) Brasilia Brazil
  • J. Gómez‐Vera
    Allergy Clinic Hospital Regional del ISSSTE ‘Lic. López Mateos’ Mexico City Mexico
  • N. A. Guldemond
    Institute of Health Policy and Management iBMG Erasmus University Rotterdam The Netherlands
  • Z. Gutter
    University Hospital Olomouc – National eHealth Centre Olomouk Czech Republic
  • T. Haahtela
    Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
  • J. Hajjam
    Centich: centre d'expertise national des technologies de l'information et de la communication pour l'autonomie, Gérontopôle autonomie longévité des Pays de la Loire, Conseil régional des Pays de la Loire Centre d'expertise Partenariat Européen d'Innovation pour un vieillissement actif et en bonne santé Nantes France
  • P. W. Hellings
    Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
  • L. Hernández‐Velázquez
    Alergologo Ensenada Mexico
  • M. Illario
    Division for Health Innovation Campania Region and Federico II University Hospital Naples (R&D and DISMET) Naples Italy
  • J. C. Ivancevich
    Servicio de Alergia e Immunologia, Clinica Santa Isabel Buenos Aires Argentina
  • E. Jares
    Libra Foundation Buenos Aires Argentina
  • G. Joos
    Department of Respiratory Medicine Ghent University Hospital Ghent Belgium
  • J. Just
    Allergology Department Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand‐Trousseau (APHP, Paris) Paris France
  • O. Kalayci
    Pediatric Allergy and Asthma Unit Hacettepe University School of Medicine Ankara Turkey
  • A. F. Kalyoncu
    Immunology and Allergy Division Department of Chest Diseases School of Medicine Hacettepe University Ankara Turkey
  • J. Karjalainen
    Allergy Centre Tampere University Hospital Tampere Finland
  • T. Keil
    Institute of Social Medicine, Epidemiology and Health Economics Charité ‐ Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry University of Wuerzburg Wuerzburg Germany
  • N. Khaltaev
    GARD Geneva Switzerland
  • L. Klimek
    Center for Rhinology and Allergology Wiesbaden Germany
  • V. Kritikos
    Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
  • I. Kull
    Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden
  • P. Kuna
    Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
  • V. Kvedariene
    Clinic of Infectious, Chest Diseases, Dermatology and Allergology Vilnius University Vilnius Lithuania
  • V. Kolek
    Department of Respiratory Medicine Faculty of Medicine and Dentistry University Hospital Olomouc Czech Republic
  • E. Krzych‐Fałta
    Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland
  • M. Kupczyk
    Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
  • P. Lacwik
    Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
  • S. La Grutta
    Institute of Biomedicine and Molecular Immunology (IBIM) National Research Council (CNR) Palermo Italy
  • D. Larenas‐Linnemann
    Clínica de Alergia, Asma y Pediatría Hospital Médica Sur México City Mexico
  • D. Laune
    Kyomed Montpellier France
  • D. Lauri
    Presidente CMMC Milano Italy
  • J. Lavrut
    Head of the Allergy Department of Pedro de Elizalde Children's Hospital Buenos Aires Argentina
  • M. Lessa
    Faculdade de Medicina da Universidade Federal da Bahia Salvador de Bahia Brazil
  • G. Levato
    Sifmed Milano Italy
  • L. Lewis
    Promotor B3 Action GRoup EIP on AHA and Senior Fellow International Foundation for Integreted Care Aberystwyth UK
  • I. Lieten
    Tech Life Valley Diepenbeek Belgium
  • A. Lipiec
    Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland
  • R. Louis
    Department of Pulmonary Medicine CHU Sart‐Tilman Liege Belgium
  • J. A. Luna‐Pech
    University of Guadalajara Guadalara Mexico
  • A. Magnan
    Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax University of Nantes Nantes France
  • J. Malva
    Faculty of Medicine Institute of Biomedical Imaging and Life Sciences (IBILI) University of Coimbra Coimbra Portugal
  • J. F. Maspero
    Argentine Association of Allergy and Clinical Immunology Buenos Aires Argentina
  • J. J. Matta‐Campos
    Hospital Regional Siglo XXI Mexico City Mexico
  • O. Mayora
    Fondazione Bruno Kessler (FBK) Trento Italy
  • M. A. Medina‐Ávalos
    Alergologo Veracruz Mexico
  • E. Melén
    Sachs’ Children and Youth Hospital, Södersjukhuset Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
  • E. Menditto
    CIRFF Federico II University Naples Italy
  • J. Millot‐Keurinck
    Caisse d'assurance retraite et de la santé au travail du Languedoc‐Roussillon (CARSAT‐LR) Montpellier France
  • G. Moda
    Regione Piemonte Torino Italy
  • M. Morais‐Almeida
    Allergy and Clinical Immunology Department Hospital CUF‐Descobertas Lisboa Portugal
  • R. Mösges
    Institute of Medical Statistics, Informatics and Epidemiology Medical Faculty University of Cologne Cologne Germany
  • A. Mota‐Pinto
    Ageing@Coimbra EIP‐AHA Reference Site Coimbra Portugal
  • J. Mullol
    Clinical & Experimental Respiratory Immunoallergy ENT Department Hospital Clínic IDIBAPS Universitat de Barcelona Barcelona Spain
  • A. Muraro
    Department of Women and Child Health Food Allergy Referral Centre Veneto Region Padua General University Hospital Padua Italy
  • R. Murray
    MedScript Ltd Dundalk, Co. Louth Ireland
  • M. Noguès
    Caisse d'assurance retraite et de la santé au travail du Languedoc‐Roussillon (CARSAT‐LR) Montpellier France
  • M. Nalin
    Telbios SRL Milan Italy
  • L. Napoli
    Consortium of Pharmacies and Services COSAFER Salerno Italy
  • H. Neffen
    Head of Respiratory Medicine Alassia Children's Hospital Center for Allergy and Immunology Santa Fe Argentina
  • R. E. O'Hehir
    Department of Allergy, Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne Vic. Australia
  • G. L. Onorato
    MACVIA‐France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
  • S. Palkonen
    EFA European Federation of Allergy and Airways Diseases Patients’ Associations Brussels Belgium
  • N. G. Papadopoulos
    Center for Pediatrics and Child Health Institute of Human Development Royal Manchester Children's Hospital University of Manchester Manchester UK
  • G. Passalacqua
    Allergy and Respiratory Diseases IRCCS San Martino Hospital‐IST‐University of Genoa Genoa Italy
  • J. L. Pépin
    Department of Pneumology CHU Grenoble Grenoble France
  • A. M. Pereira
    Allergy Unit CUF‐Porto Hospital and Institute Center for Research in Health Technologies and Information Systems, CINTESIS Universidade do Porto Porto Portugal
  • M. Persico
    Sociologist, Municipality Sorrento Italy
  • O. Pfaar
    Department of Otorhinolaryngology, Head and Neck Surgery Universitätsmedizin Mannheim, Medical Faculty Mannheim Heidelberg University Mannheim Germany
  • A. C. Pozzi
    Vice‐Presidente of IML Milano Italy
  • E. Prokopakis
    Department of Otolaryngology University of Crete School of Medicine Heraklion Greece
  • B. Pugin
    Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
  • F. Raciborski
    Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland
  • J. Rimmer
    Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
  • J. A. Rizzo
    Alergista Recife Brazil
  • C. Robalo‐Cordeiro
    Centre of Pneumology Coimbra University Hospital Coimbra Portugal
  • M. Rodríguez‐González
    Alergologo Mexico City Mexico
  • G. Rolla
    Regione Piemonte Torino Italy
  • R. E. Roller‐Wirnsberger
    Medical University of Graz Graz Austria
  • A. Romano
    Allergy Unit, Presidio Columbus, Rome Catholic University of Sacred Heart Rome Italy
  • M. Romano
    Telbios SRL Milan Italy
  • M. R. Romano
    Municipality of Salerno Salerno Italy
  • J. Salimäki
    Association of Finnish Pharmacists Helsinki Finland
  • B. Samolinski
    Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland
  • F. S. Serpa
    Allergist Vitoria Brazil
  • S. Shamai
    Institute of Medical Statistics, Informatics and Epidemiology Medical Faculty University of Cologne Cologne Germany
  • M. Sierra
    Innovación y nuevas tecnologías Salud Sector sanitario de Barbastro Barbastro Spain
  • M. Sova
    Departement of Internal Medicine University Hospital Olomouc Czech Republic
  • M. Sorlini
    IML (Lombardy Medical Initiative) Bergamo Italy
  • C. Stellato
    Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy
  • R. Stelmach
    Pulmonary Division Heart Institute (InCor) Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo Sao Paulo Brazil
  • T. Strandberg
    Center for Life Course Health Research Helsinki University Hospital, Helsinki University University of Oulu Oulu Finland
  • V. Stroetmann
    Empirica Communication and Technology Research Bonn Germany
  • R. Stukas
    Public Health Institute of Vilnius University Vilnius Lithuania
  • A. Szylling
    Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland
  • R. Tan
    Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
  • V. Tibaldi
    Regione Piemonte Torino Italy
  • A. Todo‐Bom
    Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine University of Coimbra Coimbra Portugal
  • S. Toppila‐Salmi
    Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
  • P. Tomazic
    Department of ENT Medical University of Graz Graz Austria
  • U. Trama
    Division on Pharmacy and Devices Policy Campania Region Naples Italy
  • M. Triggiani
    Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy
  • A. Valero
    Pneumology and Allergy Department Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES University of Barcelona Barcelona Spain
  • E. Valovirta
    Department of Lung Diseases and Clinical Allergology University of Turku Turku Finland
  • A. Valiulis
    Vilnius University Clinic of Children's Diseases and Public Health Institute Vilnius Lithuania
  • M. van Eerd
    Peercode DV Gerdermalsen The Netherlands
  • T. Vasankari
    FILHA Finnish Lung Association Helsinki Finland
  • A. Vatrella
    Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana” University of Salerno Salerno Italy
  • M. T. Ventura
    Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
  • M. T. Verissimo
    Faculty of Medicine Institute of Biomedical Imaging and Life Sciences (IBILI) University of Coimbra Coimbra Portugal
  • F. Viart
    ASA ‐ Advanced Solutions Accelerator Clapiers France
  • S. Williams
    International Primary Care Respiratory Group IPCRG Aberdeen UK
  • M. Wagenmann
    Department of Otorhinolaryngology HNO‐Klinik, Universitätsklinikum Düsseldorf Düsseldorf Germany
  • C. Wanscher
    EIP on AHA Coordinator Region of Southern Denmark Odense Denmark
  • M. Westman
    Department of Medicine Solna, Immunology and Allergy Unit Karolinska Institutet and Department of ENT Diseases Karolinska University Hospital Stockholm Sweden
  • M. Wickman
    Sachs’ Children and Youth Hospital Södersjukhuset, Stockholm and Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
  • I. Young
    Queen's University Belfast UK
  • A. Yorgancioglu
    Celal Bayar University Department of Pulmonology GARD Executive Committee Manisa Turkey
  • E. Zernotti
    Universidad Católica de Córdoba Córdoba Argentina
  • T. Zuberbier
    Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité‐Universitätsmedizin Berlin Berlin Germany
  • A. Zurkuhlen
    Gesundheitsregion KölnBonn ‐ HRCB Projekt GmbH Kohln Germany
  • B. De Oliviera
    EC‐CNECT‐H2, European Commission Brussels Belgium
  • A. Senn
    EC‐CNECT‐H2, European Commission Brussels Belgium

抄録

<jats:title>Abstract</jats:title><jats:p>The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (<jats:styled-content style="fixed-case">EIP</jats:styled-content> on <jats:styled-content style="fixed-case">AHA</jats:styled-content>) are to enable European citizens to lead healthy, active and independent lives whilst ageing. The <jats:styled-content style="fixed-case">EIP</jats:styled-content> on <jats:styled-content style="fixed-case">AHA</jats:styled-content> includes 74 Reference Sites. The aim of this study was to transfer innovation from an app developed by the <jats:styled-content style="fixed-case">MACVIA</jats:styled-content>‐France <jats:styled-content style="fixed-case">EIP</jats:styled-content> on <jats:styled-content style="fixed-case">AHA</jats:styled-content> reference site (<jats:italic>Allergy Diary)</jats:italic> to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (<jats:styled-content style="fixed-case">ICT</jats:styled-content>) tools (i.e. the <jats:italic>Allergy Diary</jats:italic> and <jats:styled-content style="fixed-case">CARAT</jats:styled-content>: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve the understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will be: (i) to assess the percentage of adults and elderly who are able to use the <jats:italic>Allergy Diary</jats:italic>, (ii) to study the phenotypic characteristics and treatment over a 1‐year period of rhinitis and asthma multimorbidity at baseline (cross‐sectional study) and (iii) to follow‐up using visual analogue scale (<jats:styled-content style="fixed-case">VAS</jats:styled-content>). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults.</jats:p>

収録刊行物

  • Allergy

    Allergy 73 (1), 77-92, 2017-08-24

    Wiley

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ